Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Verwiel Frank Create: Alert

All | News | Filings
Date FiledTypeDescription
06/16/2023 4 Verwiel Frank (Director) has filed a Form 4 on Intellia Therapeutics, Inc.
Txns: Granted 4,425 shares @ $0
Granted 6,473 options to buy @ $45.2, valued at $292.6k
06/16/2022 4 Verwiel Frank (Director) has filed a Form 4 on Intellia Therapeutics, Inc.
Txns: Granted 5,197 shares @ $0
Granted 7,688 options to buy @ $38.49, valued at $295.9k
06/25/2021 4 Verwiel Frank (Director) has filed a Form 4 on Intellia Therapeutics, Inc.
Txns: Granted 2,094 shares @ $0
Granted 3,382 options to buy @ $83.59, valued at $282.7k
06/19/2020 4 Verwiel Frank (Director) has filed a Form 4 on Intellia Therapeutics, Inc.
Txns: Granted 19,000 options to buy @ $20.72, valued at $393.7k
01/29/2020 4 Verwiel Frank (Director) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC
Txns: Disposed/sold 30,000 options to buy @ $7.54, valued at $226.2k
Disposed/sold 30,000 options to buy @ $4.09, valued at $122.7k
Disposed/sold 30,000 options to buy @ $2.9, valued at $87k
Disposed/sold 42,000 options to buy @ $2.18, valued at $91.6k
05/22/2019 4 Verwiel Frank (Director) has filed a Form 4 on Intellia Therapeutics, Inc.
Txns: Granted 19,000 options to buy @ $15.78, valued at $299.8k
01/25/2019 4 Verwiel Frank (Director) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC
Txns: Granted 42,000 options to buy @ $2.18, valued at $91.6k
05/21/2018 4 Verwiel Frank (Director) has filed a Form 4 on Intellia Therapeutics, Inc.
Txns: Granted 19,000 options to buy @ $25.98, valued at $493.6k
05/15/2018 4 Verwiel Frank (Director) has filed a Form 4 on AveXis, Inc.
Txns: Disposed/sold 1,106 shares @ $0
Disposed/sold 26,496 options to buy @ $20, valued at $529.9k
Disposed/sold 2,454 options to buy @ $69.25, valued at $169.9k
Disposed/sold 2,905 options to buy @ $133.8, valued at $388.7k
03/30/2018 4 Verwiel Frank (Director) has filed a Form 4 on AveXis, Inc.
Txns: Granted 1,106 shares @ $0
Granted 2,905 options to buy @ $133.8, valued at $388.7k
02/13/2018 4 Verwiel Frank (Director) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC
Txns: Granted 30,000 options to buy @ $2.9, valued at $87k
07/25/2017 4 Verwiel Frank (Director) has filed a Form 4 on Intellia Therapeutics, Inc.
Txns: Granted 38,000 options to buy @ $16.91, valued at $642.6k
06/01/2017 4 Verwiel Frank (Director) has filed a Form 4 on AveXis, Inc.
Txns: Granted 2,454 options to buy @ $69.25, valued at $169.9k
01/19/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
02/12/2016 4 Verwiel Frank (Director) has filed a Form 4 on AveXis, Inc.
Txns: Granted 18,111 options to buy @ $20, valued at $362.2k
Granted 8,385 options to buy @ $20, valued at $167.7k
01/27/2016 4 Verwiel Frank (Director) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC
Txns: Granted 30,000 options to buy @ $7.54, valued at $226.2k
12/16/2015 4 Verwiel Frank (Director) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC
Txns: Granted 30,000 options to buy @ $9.13, valued at $273.9k
10/01/2014 4 Verwiel Frank (Director) has filed a Form 4 on INTERMUNE INC
Txns: Disposed/sold 9,725 shares @ $74, valued at $719.7k
Disposed/sold 4,000 restricted stock units @ $0
Disposed/sold 10,500 options to buy @ $15.28, valued at $160.4k
Disposed/sold 6,000 options to buy @ $10.1, valued at $60.6k
Disposed/sold 6,000 options to buy @ $9.99, valued at $59.9k
Disposed/sold 8,000 options to buy @ $40.26, valued at $322.1k
06/02/2014 4 Form 4 - Statement of changes in beneficial ownership of securities
06/03/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
06/06/2012 4 Form 4 - Statement of changes in beneficial ownership of securities
04/13/2012 4 Verwiel Frank (Director) has filed a Form 4 on INTERMUNE INC
Txns: Granted 3,600 shares @ $0
Granted 625 shares @ $0
Granted 9,000 options to buy @ $15.28, valued at $137.5k
Granted 1,500 options to buy @ $15.28, valued at $22.9k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy